New Opportunities for Diabetes Mellitus Treatment
Journal Title: Міжнародний ендокринологічний журнал - Year 2013, Vol 6, Issue 54
Abstract
The paper presents the results of the study of the efficiency and safety of the insulins Insuman® Rapid, Insuman® Basal, Insuman® Comb 25 in patients with type 2 diabetes mellitus. Those medications were found to have high hypoglycemic activity in combination with hypoglycemic tablets. The medications have a good tolerance and are safe.
Authors and Affiliations
N. O. Kravchun, I. P. Romanova, T. M. Tykhonova
Keywords
Related Articles
- EP ID EP233360
- DOI -
- Views 54
- Downloads 0
Questions and Approaches to the Choice of Surgical Treatment of the Differentiated Thyroid Cancer
The differentiated thyroid carcinomas (papillary and follicular) are characterized by very favorable prognosis — the survival of patients exceeds 90 %. At the same time, tactics of their treatment is rather aggressive —...
The Level and Structure of Primary Disability due to Diabetes Mellitus Among Young People
The state of the primary disability (levels, structure, regional characteristics, causes) in diabetes mellitus among young people in Ukraine was studied. Statistical data from centers and medical and social assessment in...
Social work as demonstration of humane attitude toward a student. The right to imperfection
Article deals with the bases of social work, both as profession and as independent academic discipline. The model of unlimited improvement of students through education and their right to imperfection are also considered...
Prevalence of Growth Hormone Deficiency in Adults with Pituitary Adenomas
In this article, the authors analyzed the data of patients with pituitary tumors, of which 35 (87.5 %) suffered from growth hormone deficiency (GHD) in adults with neuroendocrine complications. Specific to GHD is a group...
News of Practical Endocrinology Following the Results of the Congress of the European Society of Endocrinology 2016
The review was made of the reports submitted in the framework of the event from the series «Endocrinology Board», held on November 23, 2016 in Kyiv, Ukraine.